Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li-Fraumeni Syndrome

被引：4

作者：

Paduano, Francesco ^{[1
,2
,3
,4
]}

Fabiani, Fernanda ^{[1
]}

Colao, Emma ^{[1
]}

Trapasso, Francesco ^{[1
,5
]}

Perrotti, Nicola ^{[1
,2
]}

Barbieri, Vito ^{[6
]}

Baudi, Francesco ^{[5
]}

Iuliano, Rodolfo ^{[1
,2
]}

机构：

[1] Magna Graecia Univ Catanzaro, Med Genet Unit, Catanzaro, Italy

[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy

[3] Tecnol Res Inst & Marrelli Hlth, Biomed Sect, Stem Cells Unit, Crotone, Italy

[4] Tecnol Res Inst & Marrelli Hlth, Biomed Sect, Med Genet Unit, Crotone, Italy

[5] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy

[6] Mater Domini Hosp, Med Oncol Unit, Catanzaro, Italy

来源：

FRONTIERS IN GENETICS | 2021年 / 12卷

关键词：

Li-Fraumeni; TP53; targeted sequencing; LFS cancers; germline TP53 variant; GENOMICS; RISK;

D O I：

10.3389/fgene.2021.734809

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Li-Fraumeni syndrome (LFS) is an inherited autosomal dominant disease characterized by a predisposition to many cancers. Germline pathogenic variants in TP53 are primarily responsible for LFS. By performing a targeted sequencing panel in a proband with liver carcinoma having a deceased son affected by osteosarcoma, we found the novel heterozygous frameshift variant c.645del (p.Ser215Argfs*32) in the TP53 gene. This variant co-segregated with typical LFS cancers in the family pedigree, consistent with the pathogenicity of this novel and previously undescribed TP53 variant.

引用

页数：5

共 50 条

[1] Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome
Said, Badr Id
Kim, Han
Tran, James
Novokmet, Ana
Malkin, David
HUMAN MUTATION, 2016, 37 (09) : 889 - 892
[2] Identification of a Novel TP53 Germline Mutation in a Large Italian Li-Fraumeni Syndrome Family
Capra, Valeria
Nozza, Paolo
Monti, Paola
Inga, Alberto
Fronza, Gilberto
PEDIATRIC BLOOD & CANCER, 2009, 52 (02) : 303 - 304
[3] Germline TP53 mutations and Li-Fraumeni syndrome
Varley, JM
HUMAN MUTATION, 2003, 21 (03) : 313 - 320
[4] Super-transactivation TP53 variant in the germline of a family with Li-Fraumeni variant
Said, Badr Id
Kim, Han
Iran, James
Novokmet, Ana
Malkin, David
CANCER RESEARCH, 2016, 76
[5] A NOVEL GERMLINE TP53 MUTATION IN A PATIENT WITH LI-FRAUMENI SYNDROME
Douglass, David
Farrar, Jason
Stine, Kimo
PEDIATRIC BLOOD & CANCER, 2019, 66
[6] A Novel Variant in the TP53 Gene Causing Li-Fraumeni Syndrome
Papadimitriou, Dimitrios T.
Stratakis, Constantine A.
Kattamis, Antonis
Glentis, Stavros
Dimitrakakis, Constantine
Spyridis, George P.
Christopoulos, Panagiotis
Mastorakos, George
Vlahos, Nikolaos F.
Iacovidou, Nicoletta
CHILDREN-BASEL, 2023, 10 (07):
[7] Two TP53 germline mutations in a classical Li-Fraumeni syndrome family
van Hest, Liselotte P.
Ruijs, Marielle W. G.
Wagner, Anja
van der Meer, Conny A.
Verhoef, Senno
van't Veer, Laura J.
Meijers-Heijboer, Hanne
FAMILIAL CANCER, 2007, 6 (03) : 311 - 316
[8] Two TP53 germline mutations in a classical Li-Fraumeni syndrome family
Liselotte P. van Hest
Mariëlle W. G. Ruijs
Anja Wagner
Conny A. van der Meer
Senno Verhoef
Laura J. van‘t Veer
Hanne Meijers-Heijboer
Familial Cancer, 2007, 6 : 311 - 316
[9] A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome
DockhornDwomiczak, B
Wolff, J
Poremba, C
Schafer, KL
Ritter, J
Gullotta, F
Jurgens, H
Bocker, W
EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1359 - 1365
[10] A rare homozygous germline missense variant of TP53 causing Li-Fraumeni syndrome
Chowdhury, Fuad
Finkbeiner, Melanie
Girgulis, Katie
Lamont, Ryan
Parboosingh, Jillian
Pecheux, Lucie
Perrier, Renee
EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1264 - 1264

← 1 2 3 4 5 →